251 related articles for article (PubMed ID: 17184637)
1. Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease.
Hueb W; Gersh BJ; Costa F; Lopes N; Soares PR; Dutra P; Jatene F; Pereira AC; Góis AF; Oliveira SA; Ramires JA
Ann Thorac Surg; 2007 Jan; 83(1):93-9. PubMed ID: 17184637
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial.
Lima EG; Hueb W; Garcia RM; Pereira AC; Soares PR; Favarato D; Garzillo CL; D'Oliveira Vieira R; Rezende PC; Takiuti M; Girardi P; Hueb AC; Ramires JA; Kalil Filho R
Am Heart J; 2013 Aug; 166(2):250-7. PubMed ID: 23895807
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
[TBL] [Abstract][Full Text] [Related]
5. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
6. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
[TBL] [Abstract][Full Text] [Related]
7. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
[TBL] [Abstract][Full Text] [Related]
8. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL
Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308
[TBL] [Abstract][Full Text] [Related]
9. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
[TBL] [Abstract][Full Text] [Related]
10. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS).
Booth J; Clayton T; Pepper J; Nugara F; Flather M; Sigwart U; Stables RH;
Circulation; 2008 Jul; 118(4):381-8. PubMed ID: 18606919
[TBL] [Abstract][Full Text] [Related]
11. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators.
Detre KM; Lombardero MS; Brooks MM; Hardison RM; Holubkov R; Sopko G; Frye RL; Chaitman BR
N Engl J Med; 2000 Apr; 342(14):989-97. PubMed ID: 10749960
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management.
Norris CM; Saunders LD; Ghali WA; Brant R; Galbraith PD; Graham M; Faris P; Dzavik V; Knudtson ML;
Can J Cardiol; 2004 Oct; 20(12):1259-66. PubMed ID: 15494780
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
[TBL] [Abstract][Full Text] [Related]
15. High mortality associated with precluded coronary artery bypass surgery caused by severe distal coronary artery disease.
Rocha AS; Dassa NP; Pittella FJ; Barbosa ON; Brito JO; Tura B; Silva PR
Circulation; 2005 Aug; 112(9 Suppl):I328-31. PubMed ID: 16159841
[TBL] [Abstract][Full Text] [Related]
16. Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease.
Breeman A; Bertrand ME; Ottervanger JP; Hoeks S; Lenzen M; Sechtem U; Legrand V; de Boer MJ; Wijns W; Boersma E
Diabetes Care; 2006 Sep; 29(9):2003-11. PubMed ID: 16936144
[TBL] [Abstract][Full Text] [Related]
17. PCI versus CABG for multivessel coronary disease in diabetics.
Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
[TBL] [Abstract][Full Text] [Related]
18. Residual high-grade angina after enhanced external counterpulsation therapy.
McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
[TBL] [Abstract][Full Text] [Related]
19. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
[TBL] [Abstract][Full Text] [Related]
20. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
Soares PR; Hueb WA; Lemos PA; Lopes N; Martinez EE; Cesar LA; Oliveira SA; Ramires JA
Circulation; 2006 Jul; 114(1 Suppl):I420-4. PubMed ID: 16820611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
